NRIPage | Articles | #glp-1 | Get Latest Political & Global Updates, Sports News, Latest National & International NRI News in India, USA & other countries around the world

GLP-1 Weight Loss Drugs Lift Pharma Profits, But Deloitte Warns of Bubble Risk

GLP-1 Drugs Drive Pharma Growth GLP-1 weight loss drugs are powering a sharp rebound in pharma R&D returns, but analysts warn the boom may be creating a risky “bubble effect” across the sector. According to Deloitte’s latest pharma innovation analysis, R&D returns among the world’s top 20 drugmakers have climbed to 7%, driven largely by obesity and diabetes treatments such as GLP-1 drugs. Obesity Drugs Overtake Oncology

Health & Wellness

04 May 2026 13:19 PM 21 views

GLP-1 Weight Loss Drugs Lift Pharma Profits, But Deloitte Warns of Bubble Risk

GLP-1 Drugs Drive Pharma Growth GLP-1 weight loss drugs are powering a sharp rebound in pharma R&D returns, but analysts warn the boom may be creating a risky “bubble effect” across the sector. According to Deloitte’s latest pharma innovation analysis, R&D returns among the world’s top 20 drugmakers have climbed to 7%, driven largely by obesity and diabetes treatments such as GLP-1 drugs. Obesity Drugs Overtake Oncology

Health & Wellness

India Sees Rise in ‘Ozempic Babies’ as GLP-1 Weight Loss Drugs Boost Fertility

India may be witnessing a quiet reproductive shift as GLP-1 weight loss drugs gain popularity across the country. Doctors in major cities are reporting an increasing number of unexpected pregnancies among women who previously struggled with infertility. Popularly referred to as “Ozempic babies” globally, these surprise conceptions are now being observed in India just months after GLP-1 injectables such as Mounjaro, Wegovy and Ozempic entered the market. While these medicines were original

Health & Wellness

20 Jan 2026 23:37 PM 232 views

India Sees Rise in ‘Ozempic Babies’ as GLP-1 Weight Loss Drugs Boost Fertility

India may be witnessing a quiet reproductive shift as GLP-1 weight loss drugs gain popularity across the country. Doctors in major cities are reporting an increasing number of unexpected pregnancies among women who previously struggled with infertility. Popularly referred to as “Ozempic babies” globally, these surprise conceptions are now being observed in India just months after GLP-1 injectables such as Mounjaro, Wegovy and Ozempic entered the market. While these medicines were original

Health & Wellness

FDA Approves First Oral Wegovy Pill, Offering Needle-Free Weight Loss Option

In a major development for obesity treatment, the US Food and Drug Administration has approved the first oral version of Wegovy, marking a significant shift in how weight-loss medications can be administered. The approval was announced by Danish pharmaceutical giant Novo Nordisk, which described the tablet

Health & Wellness

22 Dec 2025 23:55 PM 248 views

FDA Approves First Oral Wegovy Pill, Offering Needle-Free Weight Loss Option

In a major development for obesity treatment, the US Food and Drug Administration has approved the first oral version of Wegovy, marking a significant shift in how weight-loss medications can be administered. The approval was announced by Danish pharmaceutical giant Novo Nordisk, which described the tablet

Health & Wellness

Eli Lilly becomes first health-care firm to briefly reach $1 trillion market value

Eli Lilly reached a historic milestone on Friday when it briefly surpassed a $1 trillion market capitalization, becoming the first health-care company in the world to enter a territory long dominated by technology giants. The company’s stock hovered near $1,048 per share during morning trading, touching the trillion-dollar threshold before pulling back slightly. It is only the second nontechnology business in the United States to reach this valuation, following Berkshire Hathaway’s climb

Stock Market

21 Nov 2025 14:53 PM 419 views

Eli Lilly becomes first health-care firm to briefly reach $1 trillion market value

Eli Lilly reached a historic milestone on Friday when it briefly surpassed a $1 trillion market capitalization, becoming the first health-care company in the world to enter a territory long dominated by technology giants. The company’s stock hovered near $1,048 per share during morning trading, touching the trillion-dollar threshold before pulling back slightly. It is only the second nontechnology business in the United States to reach this valuation, following Berkshire Hathaway’s climb

Stock Market

Pharma executive collapses during Trump’s Oval Office event on obesity drug prices

A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his

Finance & Economics

07 Nov 2025 01:58 AM 483 views

Pharma executive collapses during Trump’s Oval Office event on obesity drug prices

A senior pharmaceutical executive collapsed during an Oval Office event where former U.S. President Donald Trump was announcing a new initiative to reduce the prices of obesity drugs. The incident caused a sudden interruption to the live broadcast of the announcement, which was centered on a major agreement between the Trump administration and leading pharmaceutical manufacturers. According to eyewitnesses, the executive, later identified as Gordon Findlay of Novo Nordisk, lost his

Finance & Economics

Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients

Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp

Finance & Economics

19 Aug 2025 14:39 PM 697 views

Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients

Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp

Finance & Economics

Are Weight Loss Drugs Really the Solution? Understanding GLP-1 and Its Impact on Obesity

The rise of anti-obesity drugs, especially GLP-1 medications like Wegovy and Mounjaro, has sparked a debate about their role in weight loss. As India’s anti-obesity drug market is expected to grow rapidly, with projections reaching ₹25,000 crore by 2030, these drugs have become a common solution for people struggling with obesity. But the question remains: are they necessary for everyone, or are they a quick fix for deeper health issues?

Health & Wellness

18 Aug 2025 10:24 AM 669 views

Are Weight Loss Drugs Really the Solution? Understanding GLP-1 and Its Impact on Obesity

The rise of anti-obesity drugs, especially GLP-1 medications like Wegovy and Mounjaro, has sparked a debate about their role in weight loss. As India’s anti-obesity drug market is expected to grow rapidly, with projections reaching ₹25,000 crore by 2030, these drugs have become a common solution for people struggling with obesity. But the question remains: are they necessary for everyone, or are they a quick fix for deeper health issues?

Health & Wellness

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

Weight-loss drugs, particularly GLP-1 medications like semaglutide and tirzepatide, are gaining traction among diabetes and obesity patients in India. While these drugs offer benefits like controlling blood sugar and aiding in weight loss, recent studies have uncovered potential eye health risks. A new study published in JAMA has linked these medications to rare but serious eye conditions, with a focus on optic nerve disorders such as non-arteritic anterior is

Health & Wellness

13 Aug 2025 04:14 AM 934 views

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

Weight-loss drugs, particularly GLP-1 medications like semaglutide and tirzepatide, are gaining traction among diabetes and obesity patients in India. While these drugs offer benefits like controlling blood sugar and aiding in weight loss, recent studies have uncovered potential eye health risks. A new study published in JAMA has linked these medications to rare but serious eye conditions, with a focus on optic nerve disorders such as non-arteritic anterior is

Health & Wellness

Wegovy Weight-Loss Injection Now Available in India

Novo Nordisk has launched its groundbreaking weight-loss drug, Wegovy, in India. This semaglutide-based injection promises to help individuals tackle obesity and related heart risks, offering a solution to India's growing health concerns. Available as a once-weekly injection, Wegovy works by mimicking the body's natural GLP-1 hormone, which regulates hunger, reduces cravings, and helps control blood sugar. Clinical trials have shown that Wegovy can res

Health & Wellness

24 Jun 2025 08:38 AM 887 views

Wegovy Weight-Loss Injection Now Available in India

Novo Nordisk has launched its groundbreaking weight-loss drug, Wegovy, in India. This semaglutide-based injection promises to help individuals tackle obesity and related heart risks, offering a solution to India's growing health concerns. Available as a once-weekly injection, Wegovy works by mimicking the body's natural GLP-1 hormone, which regulates hunger, reduces cravings, and helps control blood sugar. Clinical trials have shown that Wegovy can res

Health & Wellness

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

With the U.S. Food and Drug Administration beginning enforcement actions against compounded versions of popular weight loss medications such as semaglutide and tirzepatide—known under their brand names Wegovy and Zepbound—Americans who turned to these affordable alternatives may find themselves eyeing the murky waters of the supplement market. As access to these custom-made medications dwindles due to the end of drug shortages, a wave of unregulated supplements has hit shelves and on

Health & Wellness

22 Apr 2025 07:18 AM 1.16k views

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

With the U.S. Food and Drug Administration beginning enforcement actions against compounded versions of popular weight loss medications such as semaglutide and tirzepatide—known under their brand names Wegovy and Zepbound—Americans who turned to these affordable alternatives may find themselves eyeing the murky waters of the supplement market. As access to these custom-made medications dwindles due to the end of drug shortages, a wave of unregulated supplements has hit shelves and on

Health & Wellness

Sign In

Virginia attorney general debate set as Miyares, Jones face off amid controversy

Nirmala Sitharaman's Remarks on Work Pressure Spark Outrage Following CA's Tragic Death

Powerful 6.3 magnitude earthquake strikes Afghanistan, killing seven and injuring 150

Ketan Agarwal Murder Case: Siya Goyal Alleged Confession Shocks Pune Probe Update

Personalized Gifts

Shami Has Less Than a Week to Prove Fitness for Border-Gavaskar Trophy

China blacklists Japanese defence firms amid Taiwan row

Family Feuds and Political Blame: Jagan Mohan Reddy

Aishwarya Rai Moves Delhi High Court Against Misuse Of Images And Personality Rights

Brio Italian Grille and Bravo Italian Kitchen file for bankruptcy in 2025

#glp-1

GLP-1 Weight Loss Drugs Lift Pharma Profits, But Deloitte Warns of Bubble Risk

GLP-1 Weight Loss Drugs Lift Pharma Profits, But Deloitte Warns of Bubble Risk

India Sees Rise in ‘Ozempic Babies’ as GLP-1 Weight Loss Drugs Boost Fertility

India Sees Rise in ‘Ozempic Babies’ as GLP-1 Weight Loss Drugs Boost Fertility

FDA Approves First Oral Wegovy Pill, Offering Needle-Free Weight Loss Option

FDA Approves First Oral Wegovy Pill, Offering Needle-Free Weight Loss Option

Eli Lilly becomes first health-care firm to briefly reach $1 trillion market value

Eli Lilly becomes first health-care firm to briefly reach $1 trillion market value

Pharma executive collapses during Trump’s Oval Office event on obesity drug prices

Pharma executive collapses during Trump’s Oval Office event on obesity drug prices

Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients

Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients

Are Weight Loss Drugs Really the Solution? Understanding GLP-1 and Its Impact on Obesity

Are Weight Loss Drugs Really the Solution? Understanding GLP-1 and Its Impact on Obesity

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

New Study Links Weight-Loss Drugs to Serious Eye Conditions and Vision Loss

Wegovy Weight-Loss Injection Now Available in India

Wegovy Weight-Loss Injection Now Available in India

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

FDA Action on GLP-1 Drugs Sparks Surge in Unproven Weight Loss Supplements

Virginia attorney general debate set as Miyares, Jones face off amid controversy

Nirmala Sitharaman's Remarks on Work Pressure Spark Outrage Following CA's Tragic Death

Powerful 6.3 magnitude earthquake strikes Afghanistan, killing seven and injuring 150

Ketan Agarwal Murder Case: Siya Goyal Alleged Confession Shocks Pune Probe Update

Personalized Gifts

Shami Has Less Than a Week to Prove Fitness for Border-Gavaskar Trophy

China blacklists Japanese defence firms amid Taiwan row

Family Feuds and Political Blame: Jagan Mohan Reddy

Aishwarya Rai Moves Delhi High Court Against Misuse Of Images And Personality Rights

Brio Italian Grille and Bravo Italian Kitchen file for bankruptcy in 2025

Popular Cities